Estrategias para reducir la resistencia | 08 ENE 19

Uso racional de antibióticos

Estrategias para minimizar la resistencia a los antibióticos y maximizar su eficacia
Autor/a: Cheston B. Cunha, MD*, Steven M. Opal.  Med Clin N Am 102 (2018) 831–843
INDICE:  1. Página 1 | 2. Referencias bibliográficas
Referencias bibliográficas

1. Cunha CB, Varughese CA, Mylonakis E. Antimicrobial stewardship programs (ASPs): the devil is in the details. Virulence 2013;4:147–9.

2. Hurford A, Morris AM, Fisman DN, et al. Linking antimicrobial prescribing to antimicrobial resistance in the ICU: before and after an antimicrobial stewardship program. Epidemics 2012;4:203–10.

3. Rimawi RH, Mazer MA, Siraj DS, et al. Impact of regular collaboration between infectious diseases and critical care practitioners on antimicrobial utilization and patient outcome. Crit Care Med 2013;41:2099–107.

4. Njoku JA, Hermsen ED. Antimicrobial stewardship in the intensive care unit: a focus of potential pitfalls. J Pharm Pract 2010;23:50–60.

5. Amer MR, Akhras NS, Mahmood WA, et al. Antimicrobial stewardship program implementation in a medical intensive care unit at a tertiary care hospital in Saudi Arabia. Ann Saudi Med 2013;33:547–54.

6. Vincent JL, Opal SM, Marshall JC, et al. Sepsis definitions: time for change. Lancet 2013;381:774–5.

7. Singer M, Deutschman CS, Seymour CW, et al. The third international  onsensus

definitions for sepsis and septic shock (Sepsis-3). JAMA 2016;315(8):801–10.

8. Erdem H, Inan A, Altindis S, et al. Surveillance, control and management of infections in intensive care units in Southern Europe, Turkey and Iran—a prospective multicenter point prevalence study. J Infect 2014;68:131–40.

9. Frakking FN, Rottier WC, Dorigo-Zetsma JW, et al. Appropriateness of empirical treatment and outcome in bacteremia caused by extended-spectrum-b-lactamase-producing bacteria. Antimicrob Agents Chemother 2013;57:3092–9.

10. Martinex MN, Papich MG, Drusano GL. Dosing regimen matters: the importance of early intervention and rapid attainment of the pharmacokinetic/pharmacodynamic target. Antimicrob Agents Chemother 2012;56:2795–805.

11. Papadimitriou-Oliveris M, Marangos M, Fligou F, et al. KPC- producing Klebsiella pneumoniae enteric colonization acquired during intensive care unit stay: the significance of risk factors for its development and its impact on mortality. Diagn Microbiol Infect Dis 2013;77:169–73.

12. Pogue JM, Marchaim D, Kaye D, et al. Revisiting “older” antimicrobials in the era of multidrug resistance. Pharmacotherapy 2011;31:912–21.

13. Kahlmeter G. Defining antibiotic resistance-towards international harmonization. Ups J Med Sci 2014;119:78–86.

14. Baquero F, Coque TM, Canton R. Counteracting antibiotic resistance: breaking barriers among antibacterial strategies. Expert Opin Ther Targets 2014;31:1–11.

15. Turnidge J, Paterson DL. Setting and revising antibacterial susceptibility reakpoints. Clin Microbiol Infect 2007;20:391–408.

16. Domenico P, O’Leary R, Cunha BA. Differential effects of bismuth and salicylate salts on the antibiotic susceptibility of Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis 1992;11:170–5.

17. Cunha BA. Problems arising in antimicrobial therapy due to false susceptibility testing. J Chemother 1997;1:25–35.

18. Cunha BA. Minocycline versus doxycycline for methicillin-resistant Staphylococcus aureus (MRSA): in vitro susceptibility versus in vivo effectiveness. Int J Antimicrob Agents 2010;35:517–8.

19. Cunha BA, editor. Antibiotic essentials. 12th edition. Sudbury (MA): Jones & Bartlett; 2013.

20. Lodise TP, Butterfield J. Use of pharmacodynamic principles to inform b-lactam dosing: “S” does not always mean success. J Hosp Med 2011;6:S16–23.

21. Cunha BA. Clinical relevance of penicillin-resistant Streptococcus pneumoniae. Semin Respir Infect 2002;17:204–14.

22. Pop-Vicas A, Opal SM. The Clinical impact of multidrug-resistant gram-negative bacilli in the management of septic shock. Virulence 2014;5:206–12.

23. Cunha BA. Antibiotic resistance: effective control strategies. Lancet 001;357: 1307–8, 1101.

24. Cunha BA. Strategies to control antibiotic resistance. Semin Resp Infect 2000;21: 3–8.

25. Cunha BA. Antibiotic tissue penetration. Bull N Y Acad Med 1983;59:443–9.

26. Cunha BA. Antibiotic resistance control in the CCU. In: Cunha BA, editor. Infectious diseases in critical care medicine. 2nd edition. New York: Informa Healthcare; 2007. p. 609–24.

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2022